Blinatumomab

ATC L01FX07 · 9 markets · 11 records

Blinatumomab 9 markets · 11 records Forms

Filters

MarketAU 3 GB 1 CA 1 SG 1 ES 1 TW 1 HK 1 EU 1 FR 1

Kind

Strength

AU 3 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

0.0385 mginjectionBLINCYTO also in ES·FR
38.5 mcg/ginjectionBLINCYTO blinatumomab (rch) 38.5 microgram powder for injection vial with Intravenous (IV) solution stabiliser unknown

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名BLINCYTO ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

GB 1 records · 0 shown of 0 Source NHSBSA dm+d · Data as of 2026-10-19 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Blincyto 38.5micrograms powder for concentrate and solution for solution for infusion vials ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

0.0385 mgpowderBLINCYTO

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

55 mcg/mLinjectionBLINCYTO POWDER FOR INFUSION 35 MCG/VIAL

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

Only this ingredient

0.0385 mginjectionBLINCYTO also in AU·FR

TW 1 records · 0 shown of 0 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名BLINCYTO for Injection ×1百利妥注射劑 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名BLINCYTO POWDER FOR CONCENTRATE AND SOLUTION FOR SOLUTION FOR INFUSION 35MCG/VIAL ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名BLINCYTO ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

0.0385 mginjectionBLINCYTO 38,5 microgrammes, poudre pour solution à diluer et solution pour solution pour perfusion also in AU·ES

Side-by-side table

Strength / form / release	GB	CA	AU	SG	ES	TW	HK	EU	FR
0.0385 mgRecorded as: 38.5 mcg、38.5 microgram injection	not recorded	not recorded	BLINCYTO	not recorded	BLINCYTO	not recorded	not recorded	not recorded	BLINCYTO 38,5 microgrammes, poudre pour solution à diluer et solution pour solution pour perfusion
55 mcg/mL injection	not recorded	not recorded	not recorded	BLINCYTO POWDER FOR INFUSION 35 MCG/VIAL	not recorded	not recorded	not recorded	not recorded	not recorded
38.5 mcg/g injection	not recorded	not recorded	BLINCYTO blinatumomab (rch) 38.5 microgram powder for injection vial with Intravenous (IV) solution stabiliser	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
0.0385 mgRecorded as: 38.5 mcg powder	not recorded	BLINCYTO	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed injection	Blincyto 38.5micrograms powder for concentrate and solution for solution for infusion vials	not recorded	not recorded	not recorded	not recorded	BLINCYTO for 百利妥注射劑	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	BLINCYTO	not recorded	not recorded	not recorded	not recorded	BLINCYTO	not recorded
not disclosed Combination Blinatumomab + 对-伞花烃 unknown	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	BLINCYTO POWDER FOR CONCENTRATE AND SOLUTION FOR SOLUTION FOR INFUSION 35MCG/VIAL	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in SG · HK and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en SG · HK que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 SG · HK 有记录（未在本表显示）。另有 2 個規格/劑型僅在 SG · HK 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.